The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
pentazocine and naloxone · PENTAZOCINE 50 mg/1; NALOXONE HYDROCHLORIDE .5 mg/1 · Tablet · Oral · Sun Pharmaceutical Industries, Inc.
NDC 63304-0506-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | PENTAZOCINE 50 mg/1; NALOXONE HYDROCHLORIDE .5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | PENTAZOCINE .5 mg/1; NALOXONE HYDROCHLORIDE 50 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Sun Pharmaceutical Industries, Inc. | NALOXONE HYDROCHLORIDE .5 mg/1; PENTAZOCINE 50 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "pentazocine and naloxone — NDC 63304-0506-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63304050601.
Free to cite with attribution — see how the data is put together.